SCHEMBL22573696

SCHEMBL22573696

Cc1ccnc(NC(=O)c2cnc(-c3ccccn3)nc2N)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.56
▸ NPC1 O15118 8/20 0.55
▸ RAB9A P51151 8/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ PKM P14618 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MEN1 O00255 1/20 0.47
▸ SORT1 Q99523 2/20 0.47
▸ GRM5 P41594 1/20 0.46
▸ PTPN11 Q06124 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22574062 0.87 GRM5 (0.54) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL22573804 0.86 ATM (0.58) ATMNPC1RAB9AKMT2APOLB
SCHEMBL22573756 0.85 NPC1 (0.56) NPC1RAB9AKMT2APOLBSMN1; SMN2
SCHEMBL22573428 0.84 MEN1 (0.50) NPC1RAB9AKMT2APOLBSMN1; SMN2
SCHEMBL22573532 0.83 KDM4E (0.57) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL22573629 0.83 GRM5 (0.63) ATMNPC1RAB9AKMT2AALDH1A1
SCHEMBL22574013 0.83 CYP3A4 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL22573749 0.82 IDE (0.54) ATMNPC1RAB9AKMT2APOLB
SCHEMBL22573273 0.81 HPGDS (0.47) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL22573444 0.80 PRKCI (0.58) KMT2AALDH1A1LMNAMEN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback